Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe

NCT02597439 is registered in ClinicalTrials.gov with Rene Kahn as lead sponsor.

NCT NCT02597439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02597439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Placebo-controlled Trial in Subjects at Ultra-high Risk for Psychosis With Omega-3 Fatty Acids in Europe
Lead sponsor
Rene Kahn
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2016
Completion date
February 1, 2023
Enrollment
145 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

ultra high risk for psychosis